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Abstract 
Gap junctions are critical for the propagation of action potentials in the heart. Many autosomal 
dominant Cx40 mutations have been linked to atrial fibrillation (AF) and have showed GJ 
impairments. However, others such as L221I and V85I showed apparently no GJ impairments. 
Cells expressing L221I or V85I alone showed increased propidium iodide uptake, which was 
also the case for cells co-expressing L221I and wildtype Cx40, suggesting increased 
hemichannel opening probability. A novel AF-linked Cx45 mutant (M235L) was found to 
impair GJ function. These alterations in hemichannel or GJ function might play a role in 
promoting AF. The atria express Cx40 and Cx43 abundantly with low levels of Cx45, and may 
form heterotypic GJs. However, wildtype heterotypic Cx40/Cx43 or Cx40/Cx45 GJs were not 
functional, unless a designed Cx40 structural variant (D55N) was used, suggesting these 
heterotypic GJs are unlikely to mediate coupling in the native heart. 
Keywords 
Connexin, hemichannel, gap junction, dye uptake, dual whole-cell patch clamp, atrial 
fibrillation, heterotypic, docking, compatibility 
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Chapter 1: Introduction 
1.1 Gap junction channels 
Direct communication between apposed cells is mediated by intercellular channels known 
as gap junctions (GJs). These channels allow the passage of ions and various molecules 
less than 1 kDa in size and are important for a number of physiological processes such as 
development, metabolic cooperation, and tissue synchronicity (Evans and Martin, 2002). 
The connexin (Cx) is an integral membrane protein which constitutes the GJ channel. 21 
genes in the human genome and 20 in the mouse encode connexins, and each connexin is 
named according to its predicted molecular weight in kDa from Cx23 to Cx62 (Sohl and 
Willecke, 2004). Connexins are predicted to have a topological structure of four 
transmembrane domains (TM1-TM4), two extracellular loops (E1-E2), one cytoplasmic 
loop (CL), and intracellular amino and carboxyl terminals (NT and CT, respectively) (Fig. 
1.1A). These connexins oligomerize into hexamers to form the hemichannel (HC) (or 
connexon). Based on the connexin arrangement, these HCs can be homomeric or 
heteromeric (Evans and Martin, 2002).  
HCs exist in nearly all cells that express connexins (Saez et al., 2010), and they should not 
be confused with pannexins, which are similar in topological structure (Sosinsky et al., 
2011). When docked to form a full GJ channel, these docked HCs (or GJ channel) open to 
allow intercellular communication between cells. When undocked, however, HCs usually 
remain closed especially in cultured cells in resting conditions, but this may not be 
reflective of those in vivo, as various amounts of stimuli are present (Saez et al., 2010). The 
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open probability of HCs can be increased by various means such as membrane 
depolarization, mechanical stimulation, increased intracellular calcium ([Ca2+]i), or 
decreased extracellular calcium ([Ca2+]o (Bennett et al., 2003; De Vuyst et al., 2006; 
Goodenough and Paul, 2003; Tong et al., 2007). When opened, HCs may appear to play a 
role in paracrine signaling due to their ability to leak out ions and signalling molecules 
such as ATP, Na+, PGE2, and Ca
2+ (Fig. 1.1B) (Kar et al., 2012). Unitary conductance of 
HCs (γHC) also tend to be approximately twice that of unitary transjunctional conductance 
(γj) as demonstrated in Cx26 (Gonzalez et al., 2006). 
In order to form a GJ channel, each neighbouring cell contributes at least a HC, which dock 
head-to-head through non-covalent interactions, including hydrogen bonds. Hydrogen 
bonds are critical in docking as a reduction in the number of hydrogen bonds prevent 
docking and function altogether (Gong et al., 2013). As most cells express more than one 
connexin isoform, connexins can oligomerize in different combinations or arrangements 
as they form HCs. Based on connexin composition, the HCs can be classified as homomeric 
or heteromeric, and the GJ channels can be classified as homotypic or heterotypic (Fig. 
1.1C) (Evans and Martin, 2002). Due to the differences in amino acid sequences of 
connexins, not all homomeric heterotypic combinations produce functional GJ channels 
(Bai and Wang, 2014). It is interesting to understand which residues are important for 
heterotypic docking of non-compatible connexins. 
As previously mentioned, GJ channels provide electrical coupling between cells, which is 
critical for tissue synchronicity, such as in the heart. GJ channel function can be influenced 
by changes in potential difference between the cytoplasms of coupled cell-pairs 
(transjunctional voltage, Vj) and the absolute voltage between internal and external 
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environments of the cell (transmembrane voltage, Vm). While Gj of all vertebrate GJ 
channels is sensitive to Vj, some GJ channels are influenced by both Vj and Vm (Gonzalez 
et al., 2007). Maximal Gj for homotypic GJ channels tends to occur when Vj is equal to 
zero. Moreover, at increasing positive and negative Vj, symmetric decreases to low 
conductance values (Gmin) occur to form a bell shape as demonstrated in amphibian 
blastomeres (Harris et al., 1981). The Vj-gating properties can be described by the 
Boltzmann function for each Vj polarity (Gonzalez et al., 2007). GJs of different connexins 
show different Vj-gating properties, which may be important for their unique function. 
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Figure 1.1 Topological structures of the connexin, hemichannels, and gap junction 
channels. A. A topological structure of a connexin, an integral membrane protein, which 
has four transmembrane domains (TM1-TM4), two extracellular domains (E1-E2), one 
cytoplasmic loop (CL), and intracellular amino and carboxyl terminals (NT and CT, 
respectively). B. A connexin hemichannel. A hexamer of connexin proteins, which can 
allow the passage of a variety of ions, metabolites, and signaling molecules. C. The four 
types of gap junction channels based on different possible connexin rearrangements. The 
nomenclature on hemichannels and GJ channels are indicated below each channel. 
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1.2 Cardiac connexins 
Gap junctions are required for the rapid conduction of electrical signals for synchronized 
contractions in the heart. Under physiological conditions, action potentials originate from 
the sinoatrial (SA) node, which propagates to the atria, and slows down in the 
atrioventricular (AV) node. From there, it travels through the Purkinje-His conduction 
system and finally from the apex of the heart to the ventricles. Any disruption in the rapid 
propagation of action potentials in the heart may lead to complications which may result 
in ventricular and atrial fibrillation (AF), as examples (Hagendorff et al., 1999). 
Three major connexins, located in specific regions of the heart, are responsible for the 
heart’s electrical synchronicity (Fig. 1.2). Connexin45 (Cx45) resides in the nodal regions 
and in the Purkinje-His conduction system, including the upper and lower bundle branches, 
of the heart. Connexin40 (Cx40) resides in the atria and in the Purkinje-His conduction 
system including the upper and lower bundle branches, and connexin43 (Cx43) resides 
primarily in the atria and ventricles with some expression in the Purkinje fibres and lower 
bundle branches. (Severs et al., 2008). My thesis will focus on two of these cardiac 
connexins, namely Cx40 and Cx45. 
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Figure 1.2 Typical expression of the three major cardiac connexins: Cx40, Cx43, 
and Cx45. (Adapted from Severs et al., 2008) 
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1.2.1 Connexin40 
Cx40 is one of the three major connexins expressed in cardiac tissue. It is encoded by the 
gap junction protein alpha 5 (GJA5) gene on chromosome 1 in humans (Willecke et al., 
1990). It has also been shown to be expressed in other tissues such as smooth muscle cells 
and endothelial cells (Gabriels and Paul, 1998; Little et al., 1995). 
Cx40 is highly expressed in the atria and tends to co-localize with Cx43 (Gemel et al., 
2014). The possibility of the existence of heteromeric Cx40 and Cx43 HCs have also been 
postulated through the use of co-immunoprecipitation. This introduces a lot of possible 
variability in GJ function as multiple single channel current amplitudes were observed 
through functional studies (He et al., 1999). This provides a contrast to homomeric 
heterotypic Cx40 and Cx43 GJ channels as studies show conflicting results in regards to 
the presence of function, which may be due to docking compatibility (Bruzzone et al., 
1993; Lin et al., 2014; Valiunas et al., 2000).  
The importance of Cx40 has been shown in a number of animal models (Chaldoupi et al., 
2009). In ECG recordings of Cx40 knockout (KO) mice there were no differences in heart 
rate, but interval prolongation in each tested ECG parameter was observed, which suggests 
a decrease in conduction velocity. In addition, arrhythmia was also observed in these mice, 
which highlights the importance of the presence of Cx40 in cardiac tissue for fast and 
proper electrical conduction (Hagendorff et al., 1999; Kirchhoff et al., 1998).  
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1.2.2 Connexin45 
Cx45 is one of the principal connexins expressed in the heart, and is expressed in specific 
regions such as the nodal tissues and conduction system. It is encoded by the gap junction 
protein gamma 1 (GJC1) gene on chromosome 17 (Kanter et al., 1994). Cx45 can also be 
found in a variety of tissues such as the lung, brain, and skin (Hennemann et al., 1992). 
In the early stages of the fetus, Cx45 is highly expressed and plays a major role in heart 
development. It has been shown that Cx45 knockout mice died as early as E9.5, as after 
the initiation of vasculogenesis, blood vessel formation and smooth muscle layer 
development in the arteries were not able to proceed (Kruger et al., 2000). In adult mice, 
however, cardiomyocyte-restricted Cx45 KOs were viable but showed AV nodal 
conduction impairment. This was shown by a prolonged PQ interval on the 
electrocardiogram and prolonged AH (atria to His bundle) interval on the intracardiac 
electrogram, which highlights its importance in fetal development, especially in the heart 
(Frank et al., 2012).  
1.3 Atrial fibrillation 
Atrial fibrillation (AF) is a sustained cardiac arrhythmia which affects more than 2.5 
million Americans and 350 000 Canadians (Fuster et al., 2006). This number is expected 
to almost triple  by the year 2050, which will lead to an increased burden on the health care 
system (Go et al., 2001). In most cases, AF is believed to be secondary to systemic 
disorders or heart diseases since it will lead to structural changes in the heart which promote 
AF. These diseases include: diabetes, hypertension, coronary artery disease, and 
myocardial infarction (Benjamin et al., 1998). In approximately 30% of cases, however, 
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AF occurs on its own without association with cardiovascular diseases; this is called 
idiopathic or lone AF. The study of lone AF provides insight into the possible etiology and 
pathophysiology of AF without confounding factors that may be present when systemic or 
cardiovascular disease exists.  
Patients with AF exhibit an irregular and erratic P-wave pattern on an electrocardiogram, 
which translates into improper atrial conduction, and subsequently, contraction. 
Consequently, this may affect the electrical conduction to the ventricles, which would 
negatively affect ventricular contraction as shown by a reduced QRS-complex (Wakili et 
al., 2011). These patients would have a six-fold increase in risk for embolic stroke and a 
two-fold increase in risk for death (Wolf et al., 1991).  
1.4 Rationale and Objectives 
GJA5, the gene encoding Cx40, has been suspected to be an important player responsible 
for lone AF. In a previous study, 4 out of 15 patients had mutations in GJA5 and showed 
early onset of lone AF (Gollob et al., 2006). Two recent germline GJA5 mutants, L221I 
and V85I, were discovered by Yang and colleagues, which were shown to be autosomal 
dominant with 100% penetrance (Fig. 1.3) (Yang et al., 2010). In our lab, we have 
demonstrated that L221I and V85I showed similar Gj as wildtype Cx40, which was unusual 
since most, if not all, Cx mutants show GJ impairment (Fig 1.4). When we assessed the 
potential hemichannel activity of these mutants through the dye uptake assay, we saw 
pronounced hemichannel activity. Since these mutants are autosomal dominant, it suggests 
that one allele is enough to trigger AF. In the atria, Cx40 and Cx43 are co-expressed and 
provide the possibility that these mutants interact with either Cx40 or Cx43. It will be 
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interesting to determine whether or not any differences in hemichannel activity exist when 
these mutants are present with wildtype Cx40 or Cx43.  
As previously mentioned, differences in certain amino acid residues in the extracellular 
domains may be responsible for the incompatibility in heterotypic docking observed 
between different Cxs. Controversial data exists for the docking of Cx40 and Cx43, so it 
may be interesting to determine which residue(s) will be responsible for compatibility. In 
addition, previous studies on the heterotypic docking of mouse Cx40 and Cx45 showed 
coupling (Rackauskas et al., 2007). However, there were no studies on the heterotypic 
docking between human Cx40 and Cx45. This might be important for action potential 
propagation from the SA node to the atria and from the AV node through the ventricular 
conduction system, which is enriched with both of these connexins. 
In summary, the objectives of this study is to characterize the hemichannel function of 
Cx40 mutants co-expressed with wildtype Cx40 or Cx43, and subsequently understand 
their possible role(s) in atrial fibrillation; characterize the GJ channel function of the Cx45 
mutant and understand their possible role(s) in atrial fibrillation; and functionally study the 
role of the extracellular domains in the docking compatibility of cardiac connexins. 
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Figure 1.3 Pedigrees of the two Cx40 mutants. In the case of both (A) L221I and (B) 
V85I atrial fibrillation (denoted by the coloured shapes) co-segregated with each mutant 
(denoted by +) regardless of male (square) or female (circle). The probands are identified 
by the arrow. (Adapted from Yang et al., 2010) 
L221I
V85I
A
B
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Figure 1.4 Topological structure of Cx40 with known atrial fibrillation-linked 
mutants. Germline mutations are denoted in red and somatic mutations are denoted in 
green. (Adapted from Bai, 2014) 
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1.5 Hypotheses 
1. I hypothesize that the co-expression of the AF-linked Cx40 mutants, L221I and V85I, 
with wildtype Cx40 or Cx43 will show an increased function compared to Cx40 
hemichannels or heteromeric wildtype Cx40/Cx43 hemichannels. 
2. I hypothesize that the Cx45 mutant, M235L will alter GJ function in homotypic GJs or 
heterotypic GJs with Cx45 (or Cx43). I also hypothesize that this mutant will show a 
difference in hemichannel activity. 
3. I hypothesize that engineered variant of Cx40, D55N, will increase GJ coupling and GJ 
conductance in the docking of Cx43 and Cx45 compared to wildtype Cx40. 
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Chapter 2: Functional study with propidium iodide uptake on cells co-expressing 
atrial fibrillation-linked connexin40 mutants with connexin40 or connexin43 
2.1 Introduction 
Direct cell-cell communication via gap junctions (GJs) is critical for the rapid propagation 
of action potentials in the heart to synchronize the beating of the atria and ventricles. Gap 
junction channels are formed by a head-to-head docking of two hemichannels (HCs). HCs 
are hexamers of integral membrane proteins called connexins (Cxs). HCs composed of the 
same connexin isoform are homomeric and HCs composed of different connexin isoform 
are heteromeric (Goodenough and Paul, 2009). There are 21 human and 20 mouse genes 
that encode connexins (Sohl and Willecke, 2004). My study is focussed on Cx40 and Cx43, 
which are the major connexins expressed in the heart. Cx40 is expressed in the atria and in 
the ventricular conduction system including the Purkinje-His bundle and the upper and 
lower bundle branches. Cx43 is the most abundant connexin in the heart and it is expressed 
in the atria, ventricles, and in the Purkinje fibres and lower bundle branches. As the atria 
expresses both Cx40 and Cx43, it presents the possibility of forming homomeric or 
heteromeric HCs (Severs et al., 2008). The possibility of forming heteromeric Cx40-Cx43 
HCs have been explored through co-immunoprecipitation and functional studies. Co-
immunoprecipitation experiments were performed in vascular smooth muscle cells, which 
co-express Cx40 and Cx43. Anti-Cx40 antibodies were able to co-immunoprecipitate both 
Cx40 and Cx43, and vice versa. This would suggest that the interaction between Cx40 and 
Cx43 may be the formation of heteromeric HCs. To support this further, functional studies 
were performed on cell-pairs co-expressing Cx40 and Cx43, which showed many new 
levels of single channel conductances that were not observed when expressing Cx40 or 
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Cx43 alone. These experiments would suggest that Cx40 and Cx43 may be capable in 
forming heteromeric HCs (He et al., 1999). 
Atrial fibrillation (AF) is a sustained cardiac arrhythmia which affects nearly 2.5 million 
Americans and is expected to almost triple by 2050. This will increase the burden on the 
healthcare system (Fuster et al., 2006; Go et al., 2001). Patients with AF are twice as likely 
to experience death and six times more likely to have embolic stroke compared to those 
without AF (Wolf et al., 1991). In 70% of cases, AF is secondary to systemic disorders and 
diseases such as hypertension, diabetes, myocardial infarction, or other cardiomyopathies 
(Benjamin et al., 1998). For the remainder of cases, AF is the primary illness and is termed 
“idiopathic” or lone AF. Lone AF can be triggered by changes in genes whose protein 
products are critical in atrial function.  
Mutations in GJA5, the gene for encoding Cx40, were found to be linked to AF. In vitro 
studies of these mutations showed impaired protein trafficking and/or GJ coupling (Gollob 
et al., 2006; Sun et al., 2013). These studies provide a glimpse into the importance of proper 
GJ channel function to maintain proper physiological functions. In 2010, Yang and 
colleagues discovered two missense mutations in the gene for Cx40 which led to mutations 
L221I and V85I. Based on the pedigrees of the probands, these mutations were shown to 
be autosomal dominantly inherited with 100% penetrance as the members of the families 
who carry either mutation in one of their two Cx40 alleles developed an early onset of AF 
(Fig. 1.3) (Yang et al., 2010). 
Our lab has studied the GJ function for the two Cx40 mutants, L221I and V85I, and found 
that it was similar to wildtype Cx40 (Sun et al., 2014). This was unusual as most, if not all, 
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known connexin mutants show some level of impairment of GJ channel function compared 
to wildtype (Bai, 2014). As these mutations apparently did not alter gap junction function, 
it was possible that hemichannel function was affected. Experiments with propidium iodide 
(PI) uptake revealed that these mutants appeared to have an increased PI uptake compared 
with wildtype Cx40 (Sun et al., 2014), indicating these mutants may have an increase in 
hemichannel function. Since these are autosomal dominantly inherited mutants, one allele 
would encode the mutant and the other the wildtype. Therefore, the co-expression of Cx40 
mutants with wildtype Cx40 (or Cx43) is possible to occur in vivo. We hypothesize that 
the co-expression of the AF-linked Cx40 mutants, L221I and V85I, with wildtype Cx40 or 
Cx43 will show an increased PI uptake compared to cells expressing Cx40 alone or Cx40 
co-expressed with Cx43. 
My data showed that PI uptake was significantly reduced by the gap junction blockers, 
flufenamic acid and mefloquine, which indicate that the PI uptake was likely mediated by 
GJ HCs. In addition, the PI uptake of L221I co-expressed with Cx40 was significantly 
increased compared to the doubly-expressed wildtype Cx40. However, V85I co-expressed 
with Cx40 or both Cx40 mutants co-expressed with Cx43 showed no significant difference 
in PI uptake compared to their wildtype controls. 
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2.2 Methods 
2.2.1 Plasmid construction 
Both Cx40 mutants, L221I and V85I, and human Cx40-IRES2-EGFP or Cx43-IRES2-
EGFP genes were subcloned into a bidirectional vector (pBI-CMV1) (Fig. 2.1) (Clontech 
Laboratories Inc., Mountain View, CA) at the following sites: 
MCSI: IRES2-EGFP  Sites: BamHI and NotI 
 Cx43-IRES2-EGFP Sites: NheI and NotI 
 Cx40-IRES2-EGFP Sites: NheI and NotI 
MCSII: Cx40  Sites: EcoRI and BglII 
  L221I  Sites: EcoRI and BglII 
  V85I  Sites: EcoRI and BglII 
The human Cx40-IRES-GFP, Cx43-IRES-GFP and Cx26-GFP constructs were created as 
previously described (Sun et al., 2013; Thomas et al., 2004). The non-fusion GFP-tagged 
(V85I-IRES-GFP and L221I-IRES-GFP) constructs were generated by the QuikChange 
site directed mutagenesis kit (Stratagene, La Jolla, CA) on the respective template with the 
following primers and were sequenced to prevent any errors:  
V85I Forward 5’-CAGATCATCTTCATCTCCACGCCCT-3’  
Reverse 5’-AGGGCGTGGAGATGAAGATGATCTG-3’ 
L221I Forward  5’-CTGTCCCTCCTCATTAGCCTGGCTG-3’  
Reverse  5’-CAGCCAGGCTAATGAGGAGGGACAG-3’  
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Figure 2.1 Schematic of bidirectional vector. Two proteins of interest can be expressed 
simultaneously (Clontech Laboratories, Inc., 2009). In this case, the mutant and wildtype 
connexins are co-expressed to mimic the predicted expression patterns in the atria. 
  
Vector
MCS IIMCS I
MutantCx40/43
IRES
GFP
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2.2.2 Cell culture and transfection 
HeLa (human cervical carcinoma, American Type Culture Collection, Manassas, VA) cells 
were grown in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Burlington, 
ON) containing 4.5 g/L D-(+)-glucose, 584 mg/L L-glutamine, 110 mg/L sodium pyruvate, 
10% fetal bovine serum and 1% penicillin and streptomycin, in an incubator with 5% CO2 
at 37ºC. HeLa cells were plated at 40–60% confluence on 35 mm petri dishes 24 hours 
before transfection. For each transfection, HeLa cells were incubated with 1.0 µg of a 
cDNA construct and 2 µL of X-tremeGENE HP DNA transfection reagent (Roche, 
Mississauga, ON) in Opti-MEM I + GlutaMAX-I medium supplemented with HEPES and 
2.4 g/L sodium bicarbonate (Invitrogen) for 5 hours. Medium was then changed back to 
DMEM and cells were used for dye uptake assays approximately 24 hours after 
transfection. 
2.2.3 Dye uptake assay 
The dye uptake assay with propidium iodide (PI) was used to assess the hemichannel 
function of Cx40 and mutants with untagged GFP. HeLa cells were cultured at a low 
density to allow for isolated, single cells to be transiently transfected as described above. 
The cells were washed with regular extracellular solution (ECS) (also known as divalent 
cation-containing ECS, DCC-ECS) (in mM): 142 NaCl, 5.4 KCl, 1.4 MgCl2, 2 CaCl2, 10 
HEPES and 25 D-(+)-Glucose. The pH and osmolarity of ECS was adjusted to 7.35 and 
298 mOsm, respectively. The cells were then washed with divalent cation free-ECS (DCF-
ECS), which contains no Ca2+ or Mg2+ and 2 mM EGTA to chelate the remaining ambient 
divalent cations. The cells were incubated in DCF-ECS-containing PI (150 µM) at 37ºC 
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for 15-20 minutes to facilitate PI-uptake. After incubation, the cells were washed three 
times with DCC-ECS and the percentage of transfected cells (green with GFP) showing 
PI-uptake was measured under a fluorescent microscope (DMIRE2, Leica). Cells in pairs 
and clusters were excluded from measurement to avoid errors produced by gap junctions. 
Negative and positive controls (GFP and Cx26-GFP transfected cells, respectively) and the 
various incubation conditions (e.g. with hemichannel blockers flufenamic acid [50 µM] or 
mefloquine [25 µM]) were indicated in each experiment. For each experiment 
approximately 40–50 cells were counted to obtain a percentage of PI-uptake. The bar 
graphs were generated with 4–12 transfections. 
2.2.4 Statistical analysis 
Student’s t-test or one-way ANOVA followed by Newman-Keuls post-test were used to 
compare two or multiple groups of data, respectively, as specified. Statistical significance 
is denoted with asterisks (*, p < 0.05; **, p < 0.01; or ***, p < 0.001) on the graphs. The 
data presented on the graphs are expressed as mean ± standard error of the mean (SEM). 
Unless specified, all data were obtained from at least three independent experiments. 
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2.3 Results 
2.3.1 Gap junction channel blockers, flufenamic acid and mefloquine, reduce 
hemichannel mediated propidium iodide uptake 
A significant difference in the percentage of HeLa cells showing PI uptake in cells 
expressing either L221I (75.1 ± 2.9%, N = 12; p < 0.001) or V85I (34.2 ± 3.5%, N = 12; p 
< 0.001), compared with cells expressing Cx40 (5.0 ± 0.8%, N = 8). Two known gap 
junction channel blockers, flufenamic acid (FFA) and mefloquine (MFQ), were used to 
determine whether or not PI uptake was mediated by hemichannels. HeLa cells transiently 
transfected with L221I bathed in DCF-ECS with either FFA (7.7 ± 2.6%, N = 6; p < 0.001) 
or MFQ (21.4 ± 4.4%, N = 6; p < 0.001) and PI showed a significant decrease in the 
percentage of cells showing PI uptake compared to cells expressing L221I (75.1 ± 2.9%, 
N = 12) without blockers. HeLa cells transiently transfected with V85I bathed in DCF-
ECS with either FFA (1.6 ± 0.8%, N = 6; p < 0.001) or MFQ (7.4 ± 2.5%, N = 6; p < 0.001) 
and PI also showed a significant decrease in the percentage of cells showing PI uptake 
compared to cells expressing V85I (34.2 ± 3.5%, N = 12) without blockers (Figure 2.2 and 
2.3).  
These data show that both blockers FFA and MFQ were able to attenuate PI uptake in cells 
expressing either L221I or V85I. This would suggest that the observed PI uptake seen in 
cells expressing L221I or V85I were mediated by connexin HCs. 
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Figure 2.2 Representative fluorescent images of PI uptake of HeLa cells expressing 
various constructs in different DCF conditions. First column shows cells transfected 
with genes of interest in green from GFP. Second column shows any visible PI uptake in 
red. Third column shows the overlay of both first and second columns. Fourth column 
shows the phase images of the cells. Cells expressing L221I showed prominent PI uptake 
in DCF. Both gap junction channel blockers, FFA (50 µM) and MFQ (25 µM), reduced PI 
uptake for HeLa cells expressing L221I. Cells expressing V85I in DCF showed PI uptake. 
Both FFA and MFQ reduced PI uptake of cells expressing V85I. Scale bars in each series 
of images represent 20 µm.  
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Figure 2.3 Graph summarizing PI uptake of HeLa cells expressing L221I or V85I in 
DCF conditions. The PI uptake of cells expressing L221I in both FFA (7.7 ± 2.6%, N = 
6) and MFQ (21.4 ± 4.4%, N = 6) in DCF showed a significant reduction in PI uptake 
compared to L221I without blockers (75.1 ± 2.9%, N = 12). The PI uptake of cells 
expressing V85I in both FFA (1.6 ± 0.8%, N = 6) and MFQ (7.4 ± 2.5%, N = 6) in DCF 
showed a significant reduction in PI uptake compared to V85I without blockers (75.1 ± 
2.9%, N = 12). Negative control not shown. The number of transfections (N) are denoted 
by the numbers on the bars. Statistical significance is denoted by asterisks: ***, p < 0.001. 
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2.3.2 Co-expression of connexin40 mutant, L221I, and connexin40 showed an 
increased propidium iodide uptake 
Both AF-linked Cx40 mutants, L221I and V85I, are autosomal dominant with one gene 
allele containing the mutation and the other with wildtype Cx40. To study the effects of 
the co-expression of mutant and wildtype Cx40 we used a bidirectional vector capable of 
expressing the mutant, either L221I or V85I, and the wildtype Cx40 with untagged GFP as 
a reporter (via IRES-GFP plasmid). 
Transiently transfected HeLa cells were bathed in DCF-ECS to promote PI uptake. Both 
Cx40 mutants, L221I (61.1 ± 6.5%, N = 6) and V85I (21.5 ± 5.0%, N = 6) showed PI 
uptake, with the positive control, Cx26-GFP (95.9 ± 1.7%, N = 9) working as expected. 
The hemichannel function of Cx40 mutants co-expressed with Cx40 was assessed by using 
PI uptake (Figure 2.4). When these mutants were co-expressed with Cx40, a significant 
increase in PI uptake for L221I (9.0 ± 2.1%, N = 7; p < 0.01, Student’s t-test) was seen 
compared to cells doubly expressing wildtype Cx40 (1.3 ± 0.9%, N = 5), whereas no 
difference was seen for V85I (3.3 ± 1.4%, N = 8, Student’s t-test). When the PI uptake of 
cells co-expressing L221I or V85I with wildtype Cx40 are compared to cells expressing 
mutants alone, significant decreases in PI uptake were observed. PI uptake of cells co-
expressing L221 with Cx40 (9.0 ± 2.1%, N = 7) showed a reduced PI uptake compared to 
cells expressing only L221I (61.1 ± 6.5%, N = 6; p < 0.001, Student’s t-test). The same has 
also been observed for V85I as the PI uptake of cells co-expressing V85I and Cx40 (3.3 ± 
1.4%, N = 8) showed a reduced PI uptake compared to cells expressing V85I alone (21.5 
± 5.0%, N = 6; p < 0.001, Student’s t-test) (Figure 2.5). 
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Figure 2.4 Representative images of PI uptake of HeLa cells co-expressing Cx40 
mutants, L221I or V85I, with wildtype Cx40 in DCF conditions. Column 1 shows cells 
transfected with different constructs. Names in the color green denote the side of the 
bidirectional vector expressing GFP via IRES. Column 2 shows cells with PI uptake in red. 
Column 3 shows the overlay of both first and second columns. Column 4 shows the phase 
contrast images of HeLa cells. Cx40 mutants, L221 and V85I, co-expressed with wildtype 
Cx40 showed little PI uptake. Scale bars in each series of images represent 20 µm. 
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Figure 2.5 Graph summarizing PI uptake of HeLa cells co-expressing Cx40 mutants, 
L221I or V85I, with wildtype Cx40 in DCF-ECS. Cells co-expressing L221I and Cx40 
(9.0 ± 2.1%, N = 7) showed an increase PI uptake compared to cells doubly expressing 
Cx40 (1.3 ± 0.9%, N = 5). However, no significance increase in PI uptake was observed 
for cells co-expressing V85I and Cx40 compared to wildtype.  A reduced PI uptake was 
observed in cells co-expressing L221 with Cx40 (9.0 ± 2.1%, N = 7) compared with cells 
expressing only L221I (61.1 ± 6.5%, N = 6; p < 0.001, Student’s t-test). The PI uptake of 
cells co-expressing V85I and Cx40 (3.3 ± 1.4%, N = 8) showed a reduced PI uptake 
compared to cells expressing V85I alone (21.5 ± 5.0%, N = 6; p < 0.001, Student’s t-test). 
The number of transfections (N) is denoted by the numbers on the bars. Statistical 
significance is denoted by asterisks: **, p < 0.01  
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2.3.3 Connexin40 mutants co-expressed with connexin43 showed similar propidium 
iodide uptake to co-expressed wildtype connexin40 and connexin43 
As the atria expresses both Cx40 and Cx43 it grants the possibility of Cx40 and Cx43 
interacting with one another. Thus, it is possible for these AF-linked Cx40 mutants to 
interact with Cx43 to form heteromeric hemichannels. 
For our experiment, hemichannel function of AF-linked Cx40 mutants co-expressed with 
Cx43 was assessed by using PI uptake in DCF conditions (Figure 2.6A). The positive and 
negative controls, Cx26 and GFP, respectively, were the same as the previous experiment 
involving the co-expression of AF-linked Cx40 mutants with wildtype Cx40, since it was 
performed at the same time. PI uptake for both L221I co-expressed with Cx43 (18.7 ± 
2.4%, N = 4) and V85I co-expressed with Cx43 (18.0 ± 5.1%, N = 4) showed no significant 
difference compared with the wildtype: Cx40 co-expressed with Cx43 (20.3 ± 2.6%, N = 
4; p > 0.05, Student’s t-test) (Figure 2.6B). 
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Figure 2.6 PI uptake of HeLa cells co-expressing Cx40 mutants, L221I or V85I, with 
wildtype Cx43 in DCF conditions. (A) Representative PI uptake images of cells co-
expressing Cx40 mutants, L221I or V85I, with Cx43. Little PI uptake was observed. 
Connexin names in the colour green denote the side of the bidirectional vector expressing 
GFP via IRES. Column 1 shows GFP fluorescence. Column 2 shows cells with PI uptake 
in red. Column 3 is an overlay which is the combination of green and red fluorescence. 
Column 4 displays a phase contrast image of HeLa cells. Scale bars in each series of images 
are represented as 20 µm. (B) Graph summarizing PI uptake of cells co-expressing Cx40 
mutants, L221I or V85I, with Cx43. No significant difference was observed comparing 
cells co-expressing Cx40 mutants with Cx43 with the wildtype. The number of 
transfections (N) is denoted by the numbers on the bars. 
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2.4 Discussion 
To verify if PI uptake was mediated through connexin hemichannels, two connexin 
hemichannel blockers, FFA and MFQ, were used. Both blockers, FFA and MFQ, were 
shown to be effective in reducing PI uptake of cells expressing either AF-linked Cx40 
mutants, L221I or V85I. These data support the idea that PI uptake is mediated through 
connexin hemichannels. This portion of the study has already been published (Sun et al., 
2014).  
To assess the hemichannel function of co-expressed AF-linked Cx40 mutants, L221I or 
V85I, with Cx40 or Cx43, a bidirectional vector with a predicted 1:1 expression ratio was 
used to express both mutant and wildtype at the same time. This was done in an attempt to 
mimic native atrial tissue cells in the patients, i.e. the cardiomyocytes of the atria express 
both Cx40 and Cx43 (Severs et al., 2001). Both of these mutants linked to early onset of 
AF in the families in an autosomal dominant way and AF co-segregated with both mutant 
alleles with 100% penetrance, which indicated that one Cx40 mutant allele was sufficient 
to lead to an early onset of atrial fibrillation as displayed in the pedigree (Figure 1.3) (Yang 
et al., 2010).  
Each mutant was expressed with Cx40 or Cx43 in HeLa cells in the DCF condition, and 
assessed with PI for dye uptake. HeLa cells were incubated in PI for 15 minutes to allow 
for saturation because it is thought that hemichannels have two gates; slow loop-gating or 
fast Vj-gating, and both must be opened in order for PI to pass through (Bukauskas and 
Verselis, 2004). By assessing the hemichannel function of different heteromeric 
hemichannels formed by either L221I or V85I with Cx40 or Cx43 with the dye uptake 
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assay, L221I/Cx40 hemichannels showed an increased permeability to PI which would be 
an apparent gain-of-function compared to Cx40/Cx40 hemichannels. This partially 
supports the hypothesis that the co-expression of AF-linked Cx40 mutants with Cx40 or 
Cx43 will show an increase in hemichannel function. 
When the Cx40 mutants, L221I and V85I, were co-expressed with Cx40 or Cx43, 
reductions in PI uptake compared to L221I or V85I alone were observed. When L221I was 
co-expressed with Cx40 or Cx43, a significant reduction in PI uptake was observed 
compared to L221I alone. In addition, when V85I was co-expressed with Cx40, a 
significant reduction in PI uptake was observed compared to V85I alone. However, there 
was no difference in PI uptake between V85I alone and when V85I was co-expressed with 
Cx43. It was previously suggested that Cx40 and Cx43 were able to form heteromeric 
hemichannels due to co-immunoprecipitation and GJ channel function data (He et al., 
1999). The PI uptake data obtained would also suggest that Cx40 and Cx43 may interact 
with each other, instead of independently, to affect hemichannel function. 
Our experiments only used the dye uptake assay in the DCF condition to assess 
hemichannel function. This condition was successful in assessing hemichannel function 
when the mutants were expressed alone. However in this case, it may be possible that L221I 
or V85I co-expressed with Cx40 or Cx43 are more sensitive to other stimuli such as 
changes in membrane potential, mechanical stimulation, or intracellular Ca2+, which have 
also been shown to increase hemichannel opening probability (Bennett et al., 2003; De 
Vuyst et al., 2006; Goodenough and Paul, 2003). It is also possible that multiple conditions 
need to be employed in order to obtain a robust response. 
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Even though the hypothesis that the co-expression of Cx40 mutants with wildtype Cx40 or 
Cx43 would show an increased function compared to wildtype was not fully supported, 
since only one Cx40 mutant allele was required to cause disease, L221I/Cx40 heteromeric 
hemichannels still showed an apparent gain-of-function. In previous studies, a gain in 
hemichannel function has been shown to play a role in inherited diseases with connexin 
mutations. Cx30 mutants, G11R and A88V, linked to Clouston syndrome, which is a form 
of ectodermal dysplasia, maintained GJ function with increased hemichannel function in 
vitro. Under physiological conditions, ATP-release via hemichannels was observed 
compared to wildtype (Essenfelder et al., 2004). Other mutants in Cx32, linked to X-linked 
Charcot-Marie-Tooth (CMTX) disease, were also shown to have alterations in 
hemichannel activity. S85C, a Cx32 mutant, showed hemichannel-mediated large voltage 
dependent currents unlike the wildtype, and F235C, have leaky hemichannels that is linked 
to a neuropathy (Abrams et al., 2002; Liang et al., 2005). Cx43 mutations involved in 
oculodentodigital dysplasia (ODDD), such as G138R, were also found to show increases 
in hemichannel activities (Dobrowolski et al., 2007). It is evident that mutations that lead 
to a gain of hemichannel function provide a pathology for disease.  
A gain in hemichannel function can provide a number of ways to make the heart prone to 
arrhythmia. 1) If the hemichannels prematurely opened, Na+ and K+ would flow according 
to their concentration gradients. This would result in membrane depolarization away from 
the SA node to trigger an ectopic action potential, which may lead to uncoordinated 
contraction, and subsequently, that area of the atria will enter into a refractory period which 
would make it insensitive to any incoming action potentials from the SA node (Rudy, 
2008). 2) ATP would also be released into the extracellular space. ATP would potentially 
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bind to purinergic receptors, which subsequently trigger intracellular Ca2+ wave 
propagations. Prolonged high amounts of Ca2+ may trigger premature apoptosis, which 
could be a potential factor in the onset of AF (Dale, 2008; Ermak and Davies, 2002). 3) As 
ions and small molecules are potentially released due to hemichannel opening, critical 
metabolites such as NAD+ or ATP (Kar et al., 2012) may also be released which could 
prove detrimental to the cardiomyocytes. Although the direct mechanism may be unclear, 
this still suggests that the gain-of-function seen for L221I/Cx40 hemichannels is a prime 
suspect in the pathogenesis of lone AF. 
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Chapter 3:  Functional study of a novel autosomal dominant atrial fibrillation-
linked GJC1/connexin45 mutant 
3.1 Introduction 
Gap junction (GJ) channels are responsible for the direct communication between apposed 
cells. Various ions and small metabolites less than 1 kDa in size are able to pass through 
these intercellular channels. GJ channels are formed by the head-to-head docking of 
hemichannels (HC), which are contributed by apposed cells. HCs are hexamers of 
tetraspanning intergral membrane proteins known as connexins (Evans and Martin, 2002; 
Goodenough and Paul, 2009). There are 21 genes in the human genome and 20 genes in 
mouse genome that encode these connexins (Sohl and Willecke, 2004). 
In the heart, connexin45 (Cx45) is abundantly expressed in the sinoatrial (SA) and 
atrioventricular (AV) nodes, without other connexins. Cx45 is also expressed in the bundle 
of His, upper and lower bundle branches, and Purkinje fibres together with Cx40 and Cx43 
(Severs et al., 2008). Action potential propagation from the SA node must travel through 
the atria to get to the AV node and from there it will travel through the ventricular 
conduction system to the ventricles. It is very likely that Cx45 hemichannels will dock with 
either Cx40 or Cx43 to form heterotypic GJ channels in order to propagate the action 
potentials from the SA node to the atria.  
The importance of Cx45 has been shown in a number of mouse studies. Cx45 knockout 
mice are not viable since they die as early as E9.5 due to impairments in the formation of 
blood vessels and smooth muscle (Kruger et al., 2000). Cx45 has also been shown to be 
highly expressed throughout the heart during development, but during the maturation, 
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Cx45 expression is gradually reduced and localized into the SA and AV nodes, and the 
ventricular conduction system; low levels of Cx45 are detectable in both adult atria and 
ventricles (Alcolea et al., 1999). Cardiomyocyte-restricted Cx45-knockout mice were 
shown to be viable but showed a significant increase in AV conduction delay as implicated 
by its ECG and intracardiac measurements (Frank et al., 2012). 
Atrial fibrillation is a common cardiac arrhythmia that affects approximately 1% of the 
Canadian and American population (Fuster et al., 2006). By 2050 there will almost be a 
tripling in the number of cases of AF, which will increase the burden on the healthcare 
system (Go et al., 2001). Patients suffering from AF are typically twice as likely to die or 
six times as likely to experience stroke (Wolf et al., 1991). Based on the ECG parameters 
of patients with AF, they typically show an erratic pattern instead of a strong P-wave, which 
suggests uncoordinated activation and ineffective atrial contraction (Wakili et al., 2011). 
In approximately 70% of the cases, AF is secondary to other systemic disorders or diseases 
such as diabetes, hypertension, myocardial infarction, or coronary artery diseases 
(Benjamin et al., 1998). However, in the remaining 30% of cases, AF is a primary disease, 
which is called idiopathic or lone AF.  
A novel Cx45 mutant, M235L, was found in a lone AF patient, which was autosomal 
dominantly inherited in the patient’s family. This is the first case of a Cx45 mutation being 
linked to AF. We hypothesize that M235L will show impaired GJ function and impaired 
coupling compared to wildtype Cx45.  
My data indicated that Cx45 M235L GJs showed significantly reduced GJ coupling when 
expressed alone or heterotypically with wildtype Cx43 (or Cx45) suggesting that the 
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impairment of GJ function by M235L may be a main factor in predisposing the mutant 
carriers to AF. 
3.2 Methods 
3.2.1 Plasmid construction 
The human Cx45-IRES-GFP construct was generated by subcloning human Cx45 (in 
pBluescriptII SK(+) vector [generously provided by Dr. Eric Beyer]) into pIRES2-EGFP 
between SacI and EcoRI sites. The Cx45 sequence was checked and corrected where 
necessary. Cx43-IRES-DsRed was generated by subcloning Cx43 from Cx43-IRES-GFP 
vector into the pIRES-DsRed vector between EcoRI and BamHI sites. Cx45-IRES-DsRed 
was generated by subcloning Cx45 from Cx45-IRES-GFP vector into pIRES2-DsRed2 
vector between SacI and EcoRI sites. The Cx45-IRES-GFP vector was used as a template 
to generate the untagged individual point mutant, M235L-IRES-GFP, with the 
QuikChange site directed mutagenesis kit (Stratagene, La Jolla, CA) with the following 
primers:  
Forward - 5’-CTTCCTTCTGATATTGTATGGTGTTACAGGC-3’  
Reverse - 5’GCCTGTAACACCATACAATATCAGAAGGAAG-3’ 
All connexin clones were sequenced to confirm the accuracy of the nucleotide sequence 
with no additional variations being introduced. 
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3.2.2 Cell culture and transfection 
HeLa and N2A (human cervical carcinoma and mouse neuroblastoma cells, respectively, 
American Type Culture Collection, Manassas, VA) cells were used. Related methodology 
is described in Chapter 2. In addition, approximately 24 hours after transfection N2A cells 
were replated on glass coverslips for 2-3 hours prior to electrophysiological recording, and 
24 hours after transfection HeLa cells used in the dye uptake assay. 
3.2.3 Electrophysiological recording 
The Vj-gating property of cell pairs expressing either Cx45 or its mutant, M235L, was 
measured by dual whole-cell voltage-clamp technique as described earlier (Bai et al., 2006; 
Tong et al., 2014; Xin et al., 2010). The glass coverslips were transferred to a recording 
chamber on an inverted microscope (Leica DM IRB, Wetzlar, Germany) filled with 
extracellular fluid (ECF) at room temperature (22 – 25oC). The composition of ECF is (in 
mM): 135 NaCl, 2 CsCl, 2 CaCl2, 1 MgCl2, 1 BaCl2, 10 HEPES, 5 KCl, 5 D-(+)-glucose, 
2 Sodium pyruvate, pH 7.2, ~310 mOsm. GFP-positive and DsRed-positive paired cells 
were patched by two glass micropipettes (pipette resistance 2 - 4 MΩ) which were filled 
with intracellular fluid (ICF) containing (in mM): 130 CsCl, 10 EGTA, 0.5 CaCl2, 3 
MgATP, 2 Na2ATP, 10 HEPES, pH 7.2, ~290 mOsm. Isolated cell pairs were selected to 
test Vj-gating. One cell of the pair was clamped at 0 mV while the apposed cell was 
administrated with a series of voltage pulses given by a protocol e.g. Voltage pulses of ±20 
mV to ±100 mV in 20 mV increments for 7 seconds per pulse. The junctional currents (Ijs) 
were amplified by two Axopatch 200B amplifiers (Molecular Devices, Sunnyvale, CA) 
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with a low-pass filter (cut-off frequency 1 kHz) and digitalized at a 10 kHz sampling rate 
via an ADDA converter (Digidata 1322A, Molecular Devices, Sunnyvale, CA). 
3.2.4 Dye uptake assay 
Methodology was previously described in Chapter 2. For each experiment approximately 
40–50 cells were counted to obtain a percentage of PI-uptake. The bar graphs were 
generated with 3–9 transfections. 
3.2.5 Statistical analysis 
Methodology was previously described in Chapter 2. In addition, Fischer’s exact test was 
used to compare the coupling probability of two groups of data, as specified. 
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3.3 Results 
3.3.1 Homotypic M235L showed impaired gap junction coupling and function 
The GJ function of the Cx45 mutant, M235L, was examined through the use of the dual 
whole-cell patch clamp technique. Cell pairs expressing M235L were found to have no 
transjunctional current (Ij) in response to a Vj-pulse (Fig. 3.1A), which were different from 
cell pairs expressing wildtype Cx45. The calculated transjunctional conductance (Gj) of 
this mutant was zero (n = 17, N = 6, p < 0.001, one-way ANOVA), which was significantly 
different from that of wildtype Cx45 (Gj = 9.8 ± 3.6 nS, n = 14, N = 8). In addition, the 
coupling probability seen for M235L (0/17 cell pairs showed coupling) was significantly 
less compared to wildtype Cx45 (10/14 cell pairs showed coupling, p < 0.001, Fischer’s 
exact test) (Fig. 3.1). Homotypic Cx45 GJs were very sensitive to changes in Vj as it 
showed strong gating even at ± 20 mV Vjs (Fig. 3.2). 
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Figure 3.1 Gap junctional conductance of homotypic M235L and Cx45 gap junction 
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional 
current (Ij) for homotypic cell pairs of Cx45 and M235L (B) Only 10 out of 14 cell pairs 
showed coupling for Cx45 cell pairs. A mean Gj of 9.8 ± 3.6 nS (n = 14, N = 8) was 
observed. No cell pairs showed coupling for the homotypic pair of Cx45 mutant, M235L. 
M235L also showed significantly reduced Gj (0 nS, n = 17, N = 6, p < 0.001, one-way 
ANOVA). The number of transfections (N) are shown above or in the bars. Asterisks 
represent statistical significance:  ***, p < 0.001  
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Figure 3.2 Representative macroscopic gating of homotypic Cx45 gap junction 
channels. Macroscopic transjunctional currents (Ijs) from cell pairs of homotypic Cx45 
were shown in response to the Vj-protocol. Symmetric gating can be observed.  
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3.3.2 M235L showed impaired heterotypic coupling and function with connexin45 
Since M235L is predicted to be co-expressed with wildtype Cx45, this mutant may dock 
with wildtype Cx45. To study the functional status of M235L/Cx45 GJ channels, the dual 
whole-cell patch clamp method was used in cell pairs expressing M235L-IRES-GFP in one 
cell and Cx45-IRES-DsRed in the other cell. M235L/Cx45 cell pairs were found to have 
no transjunctional current (Ij) in response to a Vj-pulse (Fig. 3.3A), while substantial Ijs 
were recorded in cell pairs expressing wildtype Cx45-IRES-GFP in one cell and Cx45-
IRES-DsRed in the other cell. The calculated transjunctional conductance (Gj) of this 
M235L/Cx45 cell pair was zero (n = 15, N = 4), which was significantly lower than that of 
wildtype Cx45 (Gj = 2.4 ± 1.1 nS, n = 15, N = 4, p < 0.01, one-way ANOVA). In addition, 
the coupling probability seen for M235L/Cx45 (0/15 cell pairs showed coupling) was 
significantly less compared to wildtype Cx45/Cx45 (8/15 cell pairs showed coupling, p < 
0.01, Fischer’s exact test) (Fig. 3.3). 
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Figure 3.3 Gap junctional conductance of heterotypic M235L/Cx45 gap junction 
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional 
current (Ij) for homotypic and heterotypic cell pairs of Cx45 and M235L/Cx45, 
respectively (B) Only 8 out of 15 cell pairs showed coupling for Cx45 cell pairs. A mean 
Gj of 2.4 ± 1.1 nS (n = 15, N = 4) was observed. No cell pairs showed coupling for 
heterotypic cell pairs of M235L/Cx45. M235L/Cx45 also showed significantly reduced Gj 
(0 nS, n = 15, N = 4, p < 0.01, one-way ANOVA). The number of transfections (N) are 
shown above or in the bars. Asterisks represent statistical significance:  **, p < 0.01  
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3.3.3 M235L showed impaired heterotypic gap junction coupling and function with 
connexin43 
In addition to interacting with itself or Cx45, the mutant may form heterotypic GJ channels 
with Cx43 in the atria. To test this heterotypic GJ function, I measured Ijs in cell pairs with 
one cell expressing M235L-IRES-GFP and the other cell expressing Cx43-IRES-DsRed. 
M235L/Cx43 cell pairs were found to have very little Ij in response to a Vj-pulse (Fig. 
3.4A), while much higher Ijs were recorded in cell pairs expressing wildtype Cx45-IRES-
GFP in one cell and Cx43-IRES-DsRed in the other cell. The Gj of the M235L/Cx43 cell 
pair was significantly lower (0.03 ± 0.03 nS, n = 14, N = 6) than Cx45/Cx43 cell pairs 
(13.5 ± 5.2 nS, n = 13, N = 8, p < 0.01, Student’s t-test). In addition, the coupling probability 
seen for M235L/Cx43 (2/14 cell pairs showed coupling) was significantly less in 
comparison to wildtype Cx45/Cx43 (9/13 cell pairs showed coupling, p < 0.01, Fischer’s 
exact test) (Fig. 3.4). Both Cx45/Cx43 and M235L/Cx43 showed strong asymmetric Vj-
gating, however, M235L/Cx43 has smaller Ijs compared to Cx45/Cx43 (Fig. 3.5). 
3.3.4 M235L expressing cells showed no alteration in propidium iodide uptake 
The dye uptake assay was done with PI as the dye of interest in DCF conditions in HeLa 
cells to assess any potential hemichannel function of this Cx45 mutant. Very little PI uptake 
was observed for both the wildtype Cx45 and the mutant, M235L (Fig. 3.6A). There was 
no difference in PI uptake of M235L (3.1 ± 1.0%, N = 6) compared to Cx45 (5.7 ± 2.4%, 
N = 6, p > 0.05, Student’s t-test) (Fig. 3.6B), indicating no apparent difference in this Cx45 
mutant, M235L, in PI uptake.  
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Figure 3.4 Gap junctional conductance of heterotypic M235L/Cx43 gap junction 
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional 
current (Ij) for heterotypic cell pairs of Cx45/Cx43 and M235L/Cx43. (B) Only 9 out of 13 
cell pairs showed coupling for Cx45/Cx43 cell pairs. A mean Gj of 13.5 ± 5.2 nS (n = 13, 
N = 8) was observed. 2 out of 14 cell pairs showed coupling for the heterotypic cell pairs 
of M235L/Cx43. M235L/Cx43 also showed significantly reduced Gj (0.03 ± 0.03 nS, n = 
14, N = 6, p < 0.01, Student’s t-test). The number of transfections (N) are shown above or 
in the bars. Asterisks represent statistical significance:  **, p < 0.01  
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Figure 3.5 Representative macroscopic gating traces of heterotypic Cx45/Cx43 and 
M235L/Cx43 gap junction channels. Macroscopic transjunctional currents (Ijs) from cell 
pairs of heterotypic Cx45/Cx43 and M235L/Cx43 were shown in response to the Vj-
protocol. Smaller macroscopic gating can be observed in M235L/Cx43 relative to 
Cx45/Cx43. Asymmetric gating can be observed for both Cx45/Cx43 and M235L/Cx43. 
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Figure 3.6 PI uptake of HeLa cells expressing Cx45 mutant, M235L, in DCF 
conditions. (A) Representative PI uptake images of cells expressing Cx45 mutant, M235L. 
Little PI uptake was observed. Column 1 shows GFP fluorescence. Column 2 shows cells 
with PI uptake in red. Column 3 is an overlay, which is the combination of green and red 
fluorescence. Column 4 displays a phase contrast image of HeLa cells. Scale bars in each 
series of images are represented as 20 µm. (B) Graph summarizing PI uptake of cells 
expressing Cx45 mutant, M235L, wildtype Cx45, the positive control, Cx26, and the 
negative control, GFP. No significance (ns) was observed comparing cells expressing 
M235L with the wildtype. The number of transfections (N) is denoted by the numbers on 
the bars. 
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3.4 Discussion 
This is the first study of a Cx45 mutation linked to AF. Both atria-enriched connexins, 
Cx40 and Cx43, have been shown to have mutations linked to early onset of AF. (Bai, 
2014; Molica et al., 2014; Severs et al., 2008; Thibodeau et al., 2010). It would be 
interesting to characterize this Cx45 mutant in order to elucidate any potential mechanisms 
that may predispose the mutant carriers to AF. 
The dual whole-cell patch clamp technique was used to study the GJ channel function of 
the Cx45 mutant, M235L. Cell pairs with homotypic M235L GJs revealed that there was 
no GJ channel function compared to wildtype Cx45. Since M235L is an autosomal 
dominant mutation, one gene allele is enough to link disease; the other gene allele would 
still be wildtype Cx45. It is possible that in the nodal cells of the atria, that M235L can 
heterotypically dock with Cx45. In studying this, heterotypic M235L/Cx45 GJ channels 
showed no Gj which would suggest that no functional heterotypic M235L/Cx45 GJ 
channels were formed. In addition to docking with other Cx45-expressing nodal cells, it 
may be possible for the nodal cells to dock with the cardiomyocytes of the atria since the 
action potentials from the SA node must propagate through the atria to trigger contraction. 
Since the atria co-expresses Cx40 and Cx43 (Severs et al., 2008), it is possible for M235L 
to dock with either Cx40 and/or Cx43. The heterotypic GJ channel function of M235L and 
Cx43 was studied, which revealed virtually no conductance similar to the negative controls, 
and significantly lower than the conductance of Cx45/Cx43 GJ channels. Since Cx45/Cx40 
showed no GJ channel function (see Chapter 4) we did not pursue a full functional study 
of M235L/Cx40 GJs. Future studies may look into the heteromeric interactions between 
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Cx45 M235L with wildtype Cx45 and the heterotypic GJ channels of M235L with cells 
co-expressing both Cx40 andCx43, as all these GJs are predicted to exist in the heart. 
The dye uptake assay was used to study the potential hemichannel function of M235L. AF-
linked Cx40 mutants, L221I and V85I, which were previously studied, showed an increase 
in PI uptake. This may be due to a gain in hemichannel function, which could play a role 
in the pathogenesis of AF (Sun et al., 2014). M235L, however, showed very little PI uptake 
and was not statistically different from that of Cx45. However, we could not rule out the 
possibility of M235L hemichannels having an altered function when exposed to other 
specific stimuli, such as changes in transmembrane potential, mechanical stimulation, or 
increased intracellular calcium (Bennett et al., 2003; De Vuyst et al., 2006; Goodenough 
and Paul, 2003). 
It is unclear as to how impaired Cx45 GJ channel function can lead to AF since this is the 
first Cx45 mutant linked to AF. Previous studies regarding AF-linked connexin mutants 
generally show an impaired GJ channel function, such as the Cx40 mutants studied by 
Gollob et al., in 2006. One of the mutants, P88S, was a somatic mutation found in the atria 
of two patients. It showed an impaired GJ channel function compared to wildtype Cx40 
(Gollob et al., 2006). Another AF-linked Cx40 mutant, I75F, which is a germline 
autosomal dominant mutation, has also showed impaired GJ channel function (Sun et al., 
2013). It has been implicated that impaired GJ channel function in the atria introduces 
increased heterogeneity and reduced conduction velocity, which could be substrates for AF 
(Bai, 2014; Wakili et al., 2011). A similar instance of this may involve the nodal regions 
of the heart, which may contribute to AF. 
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Work with Cx45 knockout mice have been performed in previous studies. In general, Cx45 
knockouts are not viable between E9.5 and E10.5 due to impaired blood vessel formation 
and smooth muscle development (Kruger et al., 2000). As such, cardiomyocyte-restricted 
Cx45 knockout mice were used to study the role of Cx45 in the heart. Mice lacking Cx45 
in the heart showed no change in resting heart rate and no spontaneous arrhythmia, 
however, mice also express Cx30.2 and Cx40 at their nodes, which may compensate for 
the loss of Cx45 to some degree. Humans, however, do not express the Cx30.2 equivalent, 
Cx31.9, or Cx40 at their nodes, which may differ from what was observed in mice 
(Kreuzberg et al., 2009). Mice heterozygous for Cx45 showed strong Cx45 expression in 
cardiac tissues and they were viable enough to breed, but in Cx40 knockout mice, however, 
heterozygous expression of Cx45 exacerbated the issues seen in Cx40 knockouts (Frank et 
al., 2012; Kruger et al., 2006). This suggests that there may be some interplay between 
Cx40 and Cx45 regarding proper action potential propagation. Cx45 has been 
demonstrated to be critical in development and may also play a role in the maintaining 
proper cardiac conduction. As patients with M235L have been shown to develop AF it will 
be interesting to see directly how the impairment of GJ channel function of Cx45 can lead 
to AF in humans. 
During development, Cx45 is highly expressed throughout the heart. In the adult heart, 
however, Cx45 expression is reduced and localized in specific regions such as the SA and 
AV nodes, and the ventricular conduction system. During development, it may be possible 
for Cx45 and Cx40 (or Cx43) to interact in the atria (Alcolea et al., 1999). As the Cx45 
mutant, M235L, showed no transjunctional coupling in homotypic cell pairs or heterotypic 
cell pairs with Cx43 (and possibly Cx40) it may be possible for M235L to exert a dominant-
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negative effect on Cx43 (and Cx40). Other AF-linked mutants such as I75F, showed no 
transjunctional coupling conductance and exhibited dominant-negative effects on Cx43 
(and Cx40) (Sun et al., 2013). Future studies may serve to identify whether or not M235L 
exhibits dominant-negative effects on Cx43 (and Cx40) and how that may play a role in 
the development of AF. 
To conclude, M235L, a germline autosomal dominant Cx45 mutation, was recently 
discovered and is the first Cx45 mutation linked to AF. M235L did not show GJ channel 
function when expressed in cell pairs. No functional couplings were observed when M235L 
expressing cells paired with wildtype Cx45 or Cx43 expressing cells. These impairments 
in Cx45 mutant-containing GJs may alter the functional coupling in/near the SA node and 
possibly in the atria to lead to AF. In addition, it is clear that Cx45 plays a major role in 
cardiac development and cardiac conduction.  
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Chapter 4: Engineered connexin40 variant improves docking and function to 
connexin43 and connexin45 
4.1 Introduction 
The connexin (Cx) is a tetraspanning integral membrane protein. 12 connexin subunits 
comprise a single gap junction (GJ) channel and spans both membranes of apposed cells 
(Goodenough and Paul, 2009). There are 21 genes in the human genome and 20 genes in 
the mouse genome encoding connexins (Sohl and Willecke, 2004). Connexins oligomerize 
into a hexamer to form hemichannels (HCs). HCs from apposing cells dock head-to-head 
by non-covalent interactions, including hydrogen bonds, in order to form full GJ channels. 
Since many tissues express more than one connexin isoform, it is possible for different 
connexin isoforms to oligomerize together to form heteromeric HCs; this is in addition to 
forming homomeric HCs which are composed of the same connexin isoform. It is also 
possible to have two different homomeric HCs from apposing cells to dock with one 
another to form homomeric heterotypic GJ channels (Goodenough and Paul, 2009). 
In the heart, specifically in the atria, Cx40 and Cx43 are co-expressed, while Cx45 is 
enriched in the SA and AV nodes. This presents the possibility to form heterotypic GJ 
channels such as Cx40/Cx43 in the atria, or Cx40/Cx45 and Cx45/Cx43 at the border 
between atrial and nodal cells (Severs et al., 2008). Previous studies regarding the 
heterotypic compatibility between Cx40 and Cx43 revealed contradictory conclusions; 
some studies suggest that Cx40/Cx43 heterotypic GJ channels are functional whereas other 
studies suggest otherwise (Bruzzone et al., 1993; Lin et al., 2014; Rackauskas et al., 2007; 
Valiunas et al., 2000). Studies involving the heterotypic compatibility between murine 
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Cx40 and Cx45 revealed that these connexins were co-localized, and showed functional 
channels with asymmetric gating, which suggest Cx40 and Cx45 are compatible to form 
heterotypic GJ channels (Coppen et al., 1998; Elfgang et al., 1995; Rackauskas et al., 
2007), however, no study was performed on the heterotypic compatibility between human 
Cx40 and Cx45. 
In 2009, the first high resolution crystal structure of a human Cx26 GJ channel was 
resolved. Numerous hydrogen bonds (HBs) were revealed at the extracellular docking 
interface which suggest that HBs play an important role in the docking of HCs to form 
functional GJ channels (Maeda et al., 2009). The role of HBs in HC docking was also 
examined by studying the heterotypic docking between Cx26 and Cx32. Disease-linked 
mutations of Cx32 on the extracellular domain reduced the number of available HBs, which 
impaired GJ function and plaque formation. This, however, was rescued by introducing 
structurally complementary mutations in Cx26 which increased the number the HBs. The 
increase in HBs by introducing these mutations in Cx26 was able to restore GJ function 
(Gong et al., 2013). It is unknown if the heterotypic docking between human Cx40 and 
Cx43 or Cx40 and Cx45 are able to form functional heterotypic GJ channels. 
Sequence alignment of Cx40, Cx43, Cx45, and Cx26 was performed. Many amino acid 
residues appeared to be well-conserved in these connexins, in particular at the extracellular 
domains, which suggests that the Cx26 crystal structure could be used as a template to 
develop homology models in these cardiac connexins. By using the homology models, the 
HB sites suspected to be involved in docking were revealed in the extracellular domains, 
one of which was the amino acid residue at the position 54 on Cx26. On Cx40, the 
corresponding position is 55. Aspartic acid (D) is present in Cx40, which differs from 
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asparagine (N) which is found in Cx43 and Cx45 (Bai and Wang, 2014). It is possible that 
this is a critical residue in the docking between Cx40 and Cx43 as well as Cx40 and Cx45. 
We hypothesize that Cx40, Cx43, and Cx45 GJ channels possess similar structures at the 
docking interface as Cx26 and use similar residues for docking. The mutation in the Cx40 
E1 domain, D55N, which makes Cx40 similar in the residues found in Cx43 and Cx45, 
will increase the heterotypic docking of Cx40/Cx43 and Cx40/Cx45. 
For this study we generated a Cx40 variant, D55N, based on the model of docking 
compatibility by using the structure of Cx26 as a template. D55N was used to form 
heterotypic GJ channels with Cx43 and Cx45, and was able to increase GJ conductance 
when paired with Cx43 or Cx45 compared to heterotypic GJ channels formed by wildtype 
Cx40/Cx43 or Cx40/Cx45. This study suggests that the structural model of Cx26 was an 
excellent template to develop homology models for cardiac GJ channels and was able to 
help up design a proper variant to increase docking compatibility between different 
connexins. 
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4.2 Methods 
4.2.1 Plasmid construction 
The human Cx40-IRES-GFP construct was created as previously described in Chapter 2. 
Cx43-IRES-DsRed and Cx45-IRES-DsRed were created as previously described in 
Chapter 3. The Cx40-IRES-GFP vector was used as a template to generate the untagged 
individual point mutant, D55N-IRES-GFP, with the QuikChange site directed mutagenesis 
kit (Stratagene, La Jolla, CA) with the following primers:  
Forward - 5’-GATTTCCGGTGTAATACGATTCAGCC-3’  
Reverse - 5’-GGCTGAATCGTATTACACCGGAAATC-3’ 
All connexin clones were sequenced to confirm the accuracy of the nucleotide sequence 
with no additional variations being introduced. 
4.2.2 Cell culture and transfection 
Methodology was previously described in Chapter 2 Approximately 24 hours after 
transfection N2A cells were replated on glass coverslips for 2-3 hours prior to 
electrophysiological recording. 
4.2.3 Electrophysiological recording 
Methodology was previously described in Chapter 3. 
4.2.4 Statistical analysis 
Methodology was previously described in Chapter 2. 
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4.3 Results 
4.3.1 Heterotypic Cx40 D55N/Cx43 showed an increased gap junctional coupling 
conductance than Cx40/Cx43 
Based on the structural model of Cx26, the variant of Cx40, D55N, was designed and 
engineered in an attempt to improve heterotypic docking to Cx43. Cell pairs with one cell 
expressing Cx40 and the other cell expressing Cx43 showed very little transjunctional 
conductance (Gj) (0.2 ± 0.2 nS, n = 20, N = 5). However, cells expressing the Cx40 variant, 
D55N, were well-coupled to Cx43 expressing cells with a significantly higher Gj (7.1 ± 3.6 
nS, n = 15, N = 4, p < 0.05, Student’s t-test) (Fig. 4.1). 
Representative transjunctional currents (Ijs) of Cx40/Cx43 and D55N/Cx43 heterotypic 
gap junctions in response to a series of Vj-pulses show a stark contrast in the current 
amplitudes. At 10x zoom into the Ijs Cx40/Cx43 heterotypic GJs, apparent unitary channel 
currents could be observed (Fig. 4.2). Rapid Vj-gating was observed when D55N cells were 
pulsed with +Vj (or -Vj for the Cx43 expressing cell). When the opposite Vj was applied to 
D55N, a slower Vj-gating was displayed (Fig. 4.2). 
Because of the significant increase in Gj, this would suggest an improvement in heterotypic 
docking with Cx43. It appears that the use of Cx26 as a structural model was helpful for us 
in designing a variant to improve Cx40/Cx43 heterotypic docking. 
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Figure 4.1 Gap junctional conductance of heterotypic D55N and Cx43 gap junction 
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional 
current (Ij) for heterotypic cell pairs of Cx40/Cx43 and D55N/Cx43 (B) Only 6 out of 20 
cell pairs showed coupling for Cx40/Cx43 heterotypic cell pairs. Small Gj (0.2 ± 0.2 nS, n 
= 20, N = 5) was observed. 9 out of 15 cell pairs showed coupling for the heterotypic pair 
of Cx40 variant, D55N, with Cx43. D55N/Cx43 also showed significantly higher Gj (7.1 
± 3.6 nS n = 15, N = 4, p < 0.05, Student’s t-test). The number of transfections (N) are 
shown above or in the bars. Asterisks represent statistical significance:  *, p < 0.05  
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Figure 4.2 Representative macroscopic gating traces of heterotypic Cx40/Cx43 and 
D55N/Cx43 gap junction channels. Macroscopic transjunctional currents (Ijs) from cell 
pairs of heterotypic Cx40/Cx43 and D55N/Cx43 were shown in response to the Vj-
protocol. Small macroscopic gating can be observed in Cx40/Cx43. A box zoomed in at 
10x shows that Cx40/Cx43 traces are mostly single or multi-channel activities. 
Asymmetric gating can be observed for D55N/Cx43.  
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4.3.2 Heterotypic Cx40 D55N/Cx45 showed an increased gap junctional coupling 
conductance than heterotypic Cx40/Cx45 
To study heterotypic docking of human Cx40 and Cx45, we mixed cells expressing Cx40 
with cells expressing Cx45 and then studied heterotypic cell pairs with the dual whole-cell 
patch clamp method. No transjunctional currents were observed in response to a Vj-pulse 
(Fig. 4.3A, n = 20, N = 8), indicating that heterotypic Cx40/Cx45 GJs were not functional 
possibly due to an incompatibility at the docking interface. The introduction of the Cx40 
variant, D55N, was used to determine if it may be responsible for the heterotypic 
incompatibility. When Cx40 D55N expressing cells were paired with Cx43 expressing 
cells, Ijs were significantly increased in response to the same Vj-pulse (Fig 4.3). Gj was 
plotted, and was significant increased (9.9 ± 3.5 nS, n = 17, N = 6, p < 0.01, Student’s t-
test) compared to Cx40/Cx45 cell pairs (Fig. 4.3). Asymmetric Vj-gating was also observed 
as shown in the representative macroscopic trace (Fig. 4.4). 
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Figure 4.3 Gap junctional conductance of heterotypic D55N and Cx45 gap junction 
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional 
current (Ij) for heterotypic cell pairs of Cx40/Cx45 and D55N/Cx45 (B) Only 2 out of 20 
cell pairs showed coupling for Cx40/Cx45 heterotypic cell pairs. No Gj was observed 
overall. 11 out of 17 cell pairs showed coupling for the heterotypic docking of the Cx40 
variant, D55N with Cx45. D55N/Cx45 also showed significantly higher Gj (9.9 ± 3.5 nS, 
n = 17, N = 6, p < 0.01, Student’s t-test). The number of transfections (N) are shown above 
or in the bars. Asterisks represent statistical significance:  **, p < 0.01  
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Figure 4.4 Representative macroscopic gating trace of heterotypic D55N/Cx45 gap 
junction channels. Macroscopic transjunctional current (Ijs) from a cell pair of heterotypic 
D55N/Cx45 was shown in response to the Vj-protocol.  
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4.4 Discussion 
The premise for this study was to use the structural model of Cx26 as a template to predict 
the contribution of equivalent residues in cardiac connexins responsible for heterotypic 
docking compatibility. Sequence alignment revealed an odd docking-relevant residue in 
the Cx40 D55 position as the corresponding position in all other connexins is Asn (N). In 
the heterotypic docking of Cx40/Cx43 and Cx40/Cx45, a Cx40 variant, D55N, was 
engineered in an attempt to improve docking compatibility. This position was predicted to 
be involved in forming a docking HB (Bai and Wang, 2014), of which, HBs in general 
were shown to be critical in the docking of HCs to form functional GJ channels (Gong et 
al., 2013; Maeda et al., 2009).  
This study revealed that a majority of heterotypic Cx40/Cx43 cell pairs showed no 
coupling, which was similar to a number of previous studies, which suggested that 
Cx40/Cx43 GJ channels were non-functional (Bruzzone et al., 1993; Elfgang et al., 1995; 
Rackauskas et al., 2007).  
In the present study on human Cx40/Cx45 heterotypic cell pairs, no functional coupling 
was observed, which was opposite of what was seen for murine Cx40/Cx45 heterotypic 
cell pairs (Elfgang et al., 1995; Rackauskas et al., 2007). Two possible reasons exist that 
may explain this observation. Firstly, sequence alignment of human Cx40 and murine Cx40 
revealed a few differences in the NT, TM1, TM3, TM4, CL, and CT. These differences 
may have an indirect effect on the structure at the docking interface. Sequence alignment 
of human and murine Cx45 revealed a 97% homology, with differences only in CL and 
CT, which is unlikely to play an important role in the structure of the docking interface. 
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Secondly, previous studies used HeLa cells to express their connexins as opposed to N2A 
cells, which were used in this study (Elfgang et al., 1995; Rackauskas et al., 2007). In our 
lab, HeLa cells were shown to have low background coupling conductance from time to 
time (Tong and Bai, unpublished observation). It is possible that the background coupling 
conductance of HeLa cells contributed to the coupling conductance seen in murine 
heterotypic Cx40/Cx45. At present we could not rule out other possibilities or experimental 
conductions for this apparent difference. 
For both types of heterotypic GJ channels (Cx40/Cx43 and Cx40/Cx45), the introduction 
of the Cx40 variant, D55N, increased the GJ conductance (Gj). Overall, these data support 
the idea that the Cx40 D55 is an important residue for the heterotypic docking compatibility 
in heterotypic Cx40/Cx43 and Cx40/Cx45 docking. 
As the Cx40 variant, D55N, improved heterotypic docking to Cx43, detailed Vj-gating 
characterization was possible and was shown to be asymmetrical. When the D55N 
expressing cell of the heterotypic D55N/Cx43 cell pair was pulsed with +Vj, rapid Vj-
gating was observed as opposed to being pulsed with -Vj. This was consistent with what 
was reported regarding the predicted gating polarity of wildtype murine Cx40 (Gonzalez 
et al., 2007). It is possible that the differences in murine and human Cx40 may lead to a 
change in Vj-gating polarity, however, the Ijs observed for Cx40/Cx43 are too small to 
identify its Vj-gating polarity. It is very likely the introduction of D55N did not alter the 
Vj-gating polarity of Cx40, however, future studies may be directed to identifying the Vj-
gating polarity of human Cx40 to determine if that is the case. 
74 
 
The cardiac action potential propagating from the SA node (mainly expressing Cx45) to 
the atria (mainly expressing Cx40 and Cx43) can occur through heterotypic Cx40/Cx45 (or 
Cx43/Cx45) GJ channels. In the atria, action potentials could go through heterotypic 
Cx40/Cx43 and other GJ channels, and then reaching the AV node (mainly expressing 
Cx45) it propagates through Cx40/Cx45 (or Cx43/Cx45) GJ channels. A number of 
mutations on Cx40 have led to early onset of atrial fibrillation (Gollob et al., 2006; Sun et 
al., 2013). Typically, AF-linked mutants displayed an impairment of GJ function which 
may lead to a reduction in conduction velocity to promote reentry and may become a driver 
for AF (Wakili et al., 2011). Previous studies performed on Cx40 knockout mice suggested 
a reduction in conduction velocity, which may have explained the presence of arrhythmia 
that was found in some of the mice (Bagwe et al., 2005; Hagendorff et al., 1999; Kirchhoff 
et al., 1998), however, increases in conduction velocity in Cx40 knockout mice were also 
found (Beauchamp et al., 2006). Human studies regarding the relationship between Cx40 
and conduction velocity have also shown that conduction velocity was inversely 
proportional to Cx40 / [Cx40 + Cx43] expression (Kanagaratnam et al., 2002). Regardless, 
a decrease or increase in conduction velocity may both play roles in the promotion of 
heterogeneity and arrhythmia (Rohr et al., 1997). With this perspective, it is tempting to 
speculate that the introduction of D55N may provide more heterotypic compatible GJs for 
the propagation of action potentials due to the increased heterotypic coupling in 
Cx40/Cx43 and Cx40/Cx45 GJ channels. It is possible that D55N could play a beneficial 
role in the heart, however, proper models would be needed to study any effects this 
mutation will have in vivo.  
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The structural model of Cx26 appeared to be well-suited to identify critical residues 
responsible for docking incompatibility such as Cx40/Cx43 and Cx40/Cx45, and to predict 
and improve the docking ability of other incompatible connexins. It is possible that the 
combination of modeling, mutagenesis, and experimental study of the functional outcomes 
of mutant connexins can be done to understand docking compatibility in cardiac or other 
connexins. 
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Chapter 5: General discussion 
5.1 Connexins in atrial fibrillation 
The present thesis looked into the functional aspects of three cardiac mutants linked to 
atrial fibrillation (AF), Cx40 L221I, V85I, and Cx45 M235L. The Cx40 mutants, L221I 
and V85I, were co-expressed with Cx40 (or Cx43) in an attempt to mimic native atrial 
tissue expression (Severs et al., 2008), and the cells co-expressing mutant and wildtype had 
their hemichannel (HC) function assessed by the dye uptake assay. The Cx45 mutant, 
M235L, was the first Cx45 mutant linked to AF, and its gap junction (GJ) function and HC 
function were studied. For the Cx40 mutants, only L221I-Cx40 expressing cells showed 
more uptake of propidium iodide (PI) compared to wildtype, which suggests that gain of 
HC function may link these mutants to AF. In the case for Cx45 M235L, homotypic GJ 
(M235L/M235L) and heterotypic GJ (M235L/Cx45 and M235L/Cx43) functions were 
significantly reduced, but no alteration in PI uptake was observed under our experimental 
conditions. Impairment of Cx45 GJ function could be linked to AF in the mutant carriers, 
similar to several other AF-linked Cx40 and Cx43 mutants. 
AF is the most common sustained cardiac arrhythmia. AF is usually a secondary disease to 
systemic diseases or disorders such as hypertension, diabetes, myocardial infarction, or 
cardiomyopathies (Benjamin et al., 1998). In a smaller number of cases, AF without other 
cardiovascular diseases is called idiopathic or lone AF (Fuster et al., 2006). AF is 
characterized by irregular atrial action potential propagation, mainly caused by reentrant 
circuits in clinical cases. If the conduction velocity of action potentials is decreased, this 
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could allow reentrant circuits to form. Normally, the conduction velocity is too fast to have 
reentry in the atria due to the refractory period (Wakili et al., 2011). 
As cells co-expressing Cx40 and L221I showed more PI uptake compared to cells co-
expressing two wildtype Cx40, this could be attributed to the gain-of-function seen in 
L221I hemichannels. When dye uptake was performed on cells expressing L221I or V85I 
alone, significant increases in PI uptake was observed compared to cells only expressing 
wildtype Cx40 (Sun et al., 2014). In addition, no apparent impairments in GJ function were 
seen for both mutants, which suggest that the increase in HC may be the principal 
contributor to AF observed in the mutant carriers (Sun et al., 2014). A number of 
mechanisms may exist that could make the cells expressing these mutants more vulnerable 
to stress factors, which could lead to cell death and promoting reentry in the atria of the 
mutant carriers. 
The AF-linked Cx45 mutant, M235L, showed GJ impairment with no obvious alteration 
in PI-uptake compared to wildtype Cx45. Since this is the first AF-linked Cx45 mutant, no 
comparisons could be made with other AF-linked Cx45 mutants, however there are Cx40 
mutants which are similar. Mutations in Cx40 have been linked to AF (Bai, 2014; Molica 
et al., 2014), and Cx40 knockout mice have also been shown to have increased vulnerability 
to arrhythmia (Kirchhoff et al., 1998), or humans with altered Cx40 / [Cx40 + Cx43] ratios 
in the atria (Kanagaratnam et al., 2002). A number of AF-linked Cx40 mutants, such as 
I75F or P88S, showed impairment in GJ function, which may be the major contributor to 
trigger AF (Gollob et al., 2006; Sun et al., 2013). Impairment in GJ function may reduce 
coupling conductance which may lead to a reduction of conduction velocity, a predicted 
prerequisite for AF (Wakili et al., 2011). Due to the localized expression in the adult 
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myocardium, it is possible that this reduction in coupling conductance could be seen near 
the SA or AV nodes of the right atrium. 
A summary of what was observed for the AF-linked connexin mutants, L221I, V85I, and 
M235L, has been compiled in addition to known AF-linked connexin mutants that were 
previously studied (Table 5.1). 
5.2 Heterotypic docking and cardiac function 
This study also examined the heterotypic docking compatibility between cardiac 
connexins, specifically those of Cx40/Cx43 and Cx40/Cx45 (Severs et al., 2008). 
Combining the sequence alignment of Cx40, Cx43, Cx45, and Cx26, and the crystal 
structure of Cx26, we identified a potential critical residue involved in GJ docking (Bai 
and Wang, 2014; Maeda et al., 2009). Mutating this Cx40 residue, D55N was found to be 
sufficient to make it capable of docking to Cx43 and Cx45.  
Since the atria co-expresses Cx40 and Cx43, with Cx45 enriched in the SA and AV nodes, 
heterotypic interactions are a possibility for these connexins (Severs et al., 2008). I predict 
that Cx45 in the SA node may form most functional GJ channels with Cx43 and not with 
Cx40 due to docking incompatibility. Atrial cardiomyocytes may form homotypic GJs, 
heteromeric heterotypic GJs and homomeric heterotypic Cx40/Cx43 GJs. The latter, and 
possibly heteromeric heterotypic GJs, may not couple well, but can be improved by the 
introduction of Cx40 D55N. Perhaps it is possible to use this variant to increase atrial 
coupling and reduce heterogeneity as a novel treatment for AF. 
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Table 5.1 Functional status of atrial fibrillation-linked connexin mutants in Cx40, 
Cx43, and Cx45 
Connexin AF-linked mutants GJ function? HC function? 
Cx40 G38D, Q49X, I75F, 
P88S, A96S, 
M163V, L229M 
 
L221I, V85I 
Impairment 
 
 
 
Normal 
Normal (some are 
untested) 
 
 
Increased 
Cx43 G60S, G138R Impairment Increased 
Cx45 M235L Impairment Normal 
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5.3 Limitations and future studies 
A majority of this study relied on the dual whole-cell patch clamp method to determine the 
GJ function of the many mutants and cell pairs examined. Due to the potential of having 
leak current this may underestimate the amount of Ij that passes through GJ channels. In 
order to circumvent this I selected cell pairs with high plasma membrane resistance (>500 
MΩ, or leak current smaller than 20 pA with a 10 mV Vj-pulse) to improve patch clamp 
quality (Van Rijen et al., 1998). I also used Dextran Texas Red (3 kDa), which is a GJ 
impermeable dye, to confirm cell pairs with high Gj were not due to cytoplasmic bridges. 
The use of the bidirectional vector was important in the study of interactions of co-
expressing wildtype Cx40 (or Cx43) with AF-linked Cx40 mutants, L221I or V85I. It is 
predicted to be expressed at a 1:1 ratio during biosynthesis. However, we are currently 
unaware if these mutants could trigger early degradation pathways to reduce their apparent 
steady-state expression levels. A good future experiment may include a Western blot to 
confirm the 1:1 expression pattern of this vector at a steady-state expression. 
Future studies regarding the Cx45 mutant, M235L, may include assessing any potential 
dominant-negative effects the mutant may have heteromeric interaction with Cx45, Cx40, 
and Cx43, which could also contribute to the pathogenesis of AF.  
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